On September 22, 2026, the Center for Biologics Research and Development (CBRD), Chulabhorn Research Institute (CRI), through the Fire Prevention and Suppression Committee, organized a basic firefighting training course and fire evacuation drill for the 2026 Fiscal Year. The training was held for personnel working within the CBRD building to enhance their knowledge and skills in fire prevention and suppression in the event of an emergency. The CBRD of the CRI operates comprehensive research, development, and production of biologics and biopharmaceuticals, spanning from the laboratory scale to the pilot scale. Because the manufacturing process must operate continuously around the clock, the 24-hour presence of relevant personnel and researchers is required. Furthermore, the operations involve complex production equipment and support systems, alongside the potential use of materials and chemicals that carry a high risk of catching fire and spreading easily. Given these operational characteristics, preparing for life safety and asset protection is a critical mission that must be carried out continuously. For this training session, General Charn Boonpraserth, Vice President for Special Activities of the CRI and Chairman of the Fire Prevention and Suppression Committee, presided over the opening ceremony at Meeting Room 1, CRI Convention Center. More than 100 personnel working within the CBRD, including security officers, and contracted cleaning staff, attended the training. The CRI was honored to have...
The Office of Research, Chulabhorn Research Institute, organized a “Big Cleaning Day” activity to promote environmental health and foster a safe and hygienic workspace. On July 23, 2026, the Office of Research, Chulabhorn Research Institute (CRI), held its annual “Big Cleaning Day” for 2026 from 9:00 a.m. to 5:00 p.m. at the Chemistry Research Building and the Biomedical Science Building. The event aimed to promote tidiness, enhance safety, and create a positive working environment. The activity fostered a strong spirit of cooperation, with personnel from both administrative offices and laboratories/units actively joining forces to clean and organize their workspaces together. On this occasion, Dr. Chantragan Phiphopmongkol, Associate Vice President for Research, along with Assoc. Prof. Nardtida Tumrasvin, Director, Office of Research, expressed their appreciation to all staff members whose active involvement drove the activity to a successful conclusion. In addition to improving the physical surroundings and promoting good workplace hygiene, this year’s Big Cleaning Day also supported CRI’s operations in alignment with environmental health campaigns commemorating “Thai Environmental Health Day” (July 4). The initiative further reinforces the Institute’s ongoing commitment to being an organization dedicated to sustainable health, hygiene, and environmental care. Office of ResearchJuly 24, 2026
On July 3, 2026, Assoc. Prof. Dr. Panida Navasumrit, Senior Research Scientist II, Laboratory of Environmental Toxicology, representing the Chulabhorn Research Institute (CRI), attended a blessing ceremony on the auspicious occasion of the Birthday Anniversary of Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana at the “Thai Environmental Health Day 2026 ” observed on July 4th, organized by the Department of Health, Ministry of Public Health, under the theme “Scaling Up Environmental Health for a Low-Carbon Society and Better Well-Being”. Dr. Sopon Iamsirithaworn, Deputy Permanent Secretary of the Ministry of Public Health, presided over the opening ceremony, which was held in the Jupiter Room, 3rd Floor, Miracle Grand Convention Hotel, Bangkok. At this event, the CRI participated in a research exhibition on environmental health. The research focuses on promoting the well-being of the people, including studies on chemicals and pollutants in the environment to identify bioindicators that can be used to assess the exposure risks and predict the incidence of cancer and other chronic diseases, the search for bioindicators to diagnose and screen cancer patients, the development of bioindicators to indicate the contamination of residues and antibiotics in the environment which result in antimicrobial resistance, the development of rapid diagnostic tests for antimicrobial resistance, as well as the development of biologics, herb-based drugs, and chemical drugs to build...
The Chao Phya Abhaibhubejhr Hospital Foundation, under the Royal Patronage of Her Royal Highness Princess Bejaratana Rajasuda Sirisobha Phannavadi, in collaboration with the Department of Thai Traditional and Alternative Medicine, organized the “23rd Thailand Herbal EXPO 2026” from July 2–5, 2026, at Hall 12, IMPACT Exhibition and Convention Center, Muang Thong Thani. The event’s objective was to drive and elevate Thai herbs to international standards. On July 3, 2026, Assoc. Prof. Dr. Jutamaad Satayavivad, Vice President for Scientific Affairs and Director, Laboratory of Pharmacology, Chulabhorn Research Institute, served as an expert lecturer in a seminar session focused on updating recent advances in herbal research. She delivered a lecture entitled “How the Dissolution of Capsule Drug Impacts Treatment: A Case Study of Fa Thalai Chon” at the Abhaibhubejhr Herb booth. The lecture provided important scientific and medical knowledge to ensure that the public and interested individuals have a correct understanding of the disintegration and dissolution efficiency of herbal capsules, which directly impacts absorption and treatment. The session also aimed to raise public awareness and promote the correct, appropriate, and maximally safe application of Thai herbal medicines in daily life. Office of ResearchJuly 16, 2026
On June 23, 2026, Dr. Piyachat Chuysinuan, Senior Research Scientist II at the Laboratory of Organic Synthesis, Chulabhorn Research Institute (CRI), attended the Internationally Outstanding Inventors Awards Ceremony as part of the Thailand Research Expo 2026. The event took place at the World Ballroom on the 23rd floor of the Centara Grand & Bangkok Convention Centre at CentralWorld, Bangkok. The ceremony was held to recognize Thai inventors and researchers who have secured awards at international competitions. Dr. Piyachat received the certificate in honor of the CRI’s Laboratory of Organic Synthesis’s outstanding success at the Seoul International Invention Fair 2025 (SIIF 2025), held in Seoul, Republic of Korea, from December 3–6, 2025. At that fair, the laboratory proudly took home the highest accolade, the “Grand Prize,” alongside a “Bronze Medal.” During the ceremony, Prof. Dr. Yodchanan Wongsawat, Deputy Prime Minister and Minister of Higher Education, Science, Research and Innovation (MHESI), presented the certificates. This initiative aims to honor and boost the morale of Thai researchers whose achievements have brought international acclaim to the country. It also seeks to encourage the tangible application of research, inventions, and innovations for national development. This prestigious recognition marks yet another remarkable milestone and success for the researchers at the Chulabhorn Research Institute. Office of Research July 3, 2026
Nihon Denkei (Thailand) Co., Ltd., represented by Mr. Ryoji Yoshino, Managing Director, and Ms. Nithaya Panvanichkul from the Thailand branch management team, has donated medical research and public health equipment valued at THB 364,555.58 to the Chulabhorn Foundation. The donation was received by Dr. Chantragan Phiphobmongkol, Associate Vice President for Research at the Chulabhorn Research Institute, together with a team of researchers. The handover took place at the Chemical Research Building, Chulabhorn Research Institute, on Thursday, May 14, 2026. This donation marks the second consecutive year of support from Nihon Denkei (Thailand) Co., Ltd., aimed at promoting and developing the nation’s medical and public health research. Office of Research May 26, 2026
On April 28, 2026, Dr. Pakakrong Kwankhao, Pharm.D., Herbal Medicine Production Manager, Chao Phya Abhaibhubejhr Hospital, led a delegation of personnel at the Chao Phya Abhaibhubejhr Hospital and the Chao Phya Abhaibhubejhr Hospital Foundation under the Royal Patronage of Her Royal Highness Princess Bejaratana Rajasuda Sirisobha Phannavadi on a study visit to observe the research and development of herbs at the Laboratory of Pharmacology and Analytical Section, Food and Drug Quality Unit (FDQ), Office of Research, Chulabhorn Research Institute (CRI). Assoc. Prof. Dr. Jutamaad Satayavivad, Vice President for Scientific Affairs and Director, Laboratory of Pharmacology of the CRI, welcomed the delegation then held discussions with the visiting team, providing advice on the research of herbs, particularly research on Fa Thalai Chon, exchanging experience, as well as recommending research directions for herbs to meet quality system and safety standards. On this occasion, the delegation had the opportunity to visit the modern laboratory of the Analytical Section, which is certified to the ISO/IEC 17025 standard, for the testing of heavy metals in food and active ingredients in the Fa Thalai Chon products, as well as to observe dissolution testing of the Fa Thalai Chon capsules at the Laboratory of Pharmacology. This study visit and exchange of knowledge constituted a collaborative activity between the CRI and the external agency with widely recognized expertise...
On March 30, 2026 at 2.00 p.m., the Chulabhorn Research Institute (CRI) and Panaosod Co., Ltd. held a press conference to launch the product “Fa Thalai Chon Extract Capsule PC-1999 Brand” (PC-1999), an innovation derived from a Thai herb with fever-relieving properties. Assoc. Prof. Dr. Chusak Limsakul, Vice President for Administration, Building and Grounds of the CRI and Chairman of the ceremony, together with executives of the CRI and Panaosod Co., Ltd., attended the event which was held in the Meeting Room 1 at the CRI Convention Center. A seminar entitled “Why Fa Thalai Chon PC-1999?” was also held during the event. Assoc. Prof. Dr. Jutamaad Satayavivad, Vice President for Scientific Affairs and Director, Laboratory of Pharmacology of the CRI, Professor Emeritus Sayomporn Sirinavin, M.D., Lecturer, Division of Infectious Disease, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Assoc. Prof. Dr. Duangchit Panomvan Na Ayudhya, Advisor, Translational Research Unit of the CRI, and Mr. Pisanu Uchuwat, Chief Executive Officer of Panaosod Co., Ltd. shared insights into the research and development process, from laboratory research to the technology transfer of extract production and the prototype manufacturing of the standardized Fa Thalai Chon product for the industrial sector, with a focus on advancing innovation and increasing the product’s commercial value. Furthermore, a video presentation was shown to introduce the product, with the background...
The Chulabhorn Research Institute (CRI) was awarded a Plaque of Honor for the Consumer Protection Research Network by the Food and Drug Administration, Ministry of Public Health, at the National Thai FDA Forum 2026 held under the theme “From Local to Global: Research Builds the Foundation, Standards Build the Reputation, Reaching International Recognition”, on February 27, 2026 at the Vayupak Convention Center, Centara Life Government Complex Hotel & Convention Centre, Chaeng Watthana, Bangkok. On this occasion, Assoc. Prof. Dr. Jutamaad Satayavivad, Vice President for Scientific Affairs of the CRI, representing the Institute, received a “Plaque of Honor for the Consumer Protection Research Network” from Dr. Supattra Boonserm, Pharmacist, Secretary-General of the Food and Drug Administration, Ministry of Public Health. The award aims to honor research network organizations that have cooperated with the Food and Drug Administration, leading to empirical research that has concretely benefited consumer protection on health products. The CRI was one of eight organizations selected to receive this prestigious award. This recognition reflects the CRI’s commitment for over three decades as a research network in Thailand, with a strong emphasis on promoting and advancing research work, as well as developing new innovation to meet international safety standards, leading to elevating the quality of life of the Thai people and fostering the nation’s development in a sustainable manner. Scene...
Dr. Poramate Songthammawat, a research scientist at the Laboratory of Medicinal Chemistry, Chulabhorn Research Institute, has received the ACES-CST Early Career Award for Contribution to Organic Chemistry 2025. He was recognized for his research entitled “Total Synthesis of Morusalisin A.” The award was presented at the Pure and Applied Chemistry International Conference 2026 (PACCON 2026), held under the theme “The Global Future of CHEMISTRY with AI.” The event took place from February 12–14, 2026, at the King Naresuan the Great Exhibition and Convention Center (KNECC) in Phitsanulok Province, Thailand. The conference was organized by the Chemical Society of Thailand under the Patronage of Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana. Office of ResearchFebruary 26, 2026
Attention has been drawn to Reels video clip disseminating fake news on social media concerning the claim that “the Chulabhorn Research Institute” was involved with a product under the name Safemild through Facebook Fanpage, such as women’s health https://www.facebook.com/reel/1093706536127321 and Safemild women’s skin health https://www.facebook.com/61586526503202/videos/1583605859619409 . In the advertisements, the Reels video clip claimed that the product was made from ginseng extract with the property of reducing facial wrinkles and that the product was jointly developed with the Chulabhorn Research Institute. The Chulabhorn Research Institute (CRI) would like to officially clarify that the CRI had no involvement whatsoever in the research, production, sale, or advertisement of the product Safemild. The use of the name or information of the Chulabhorn Research Institute in such nature constitutes an unauthorized act and dissemination of distorted information, misleading the public and affecting the image of the CRI. The Chulabhorn Research Institute seeks the public’s cooperation in checking information from reliable sources and following information and news relevant to the CRI via the CRI’s official website and social media only. General Administration Division, Office of Administration, and Public Relations Section, Office of the President January 16, 2026
We use cookies to improve performance. and good experience using your website. You can study details at Cookies policy and can manage your own privacy by clicking on Settings
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.